Literature DB >> 7086969

Biological and biochemical studies of African green monkey lymphotropic papovavirus.

K K Takemoto, A Furuno, K Kato, K Yoshiike.   

Abstract

The growth of African green monkey lymphotropic papovavirus (LPV) in human lymphoblastoid cell line BJA-B was found to be slow and inefficient due to the accumulation of defective particles. An analysis of molecularly cloned LPV DNAs showed that 3 of 19 clones had DNAs that were longer (5.1 kilobases) than the DNAs of the other clones. The 5.1-kilobase DNA was infectious for BJA-B cells, whereas the shorter (4.8-kilobase) molecules were defective. Unlike the wild-type virus, stocks of LPV made from cloned, infectious DNAs were homogeneous and had higher titers. Using stocks of nondefective LPV, we investigated other biological properties. LPV replication in another human B-lymphoblastoid cell line was observed. The virus did not cause tumors when it was inoculated into newborn hamsters. Serological surveys of human and nonhuman primate sera indicated that virtually all primates, including humans, show evidence of infection by viruses antigenically related to LPV.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7086969      PMCID: PMC256876          DOI: 10.1128/JVI.42.2.502-509.1982

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  General method for the isolation of plasmid deoxyribonucleic acid.

Authors:  P Guerry; D J LeBlanc; S Falkow
Journal:  J Bacteriol       Date:  1973-11       Impact factor: 3.490

2.  Nature of Col E 1 plasmid replication in Escherichia coli in the presence of the chloramphenicol.

Authors:  D B Clewell
Journal:  J Bacteriol       Date:  1972-05       Impact factor: 3.490

3.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

4.  Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran.

Authors:  J H McCutchan; J S Pagano
Journal:  J Natl Cancer Inst       Date:  1968-08       Impact factor: 13.506

5.  Terminal deoxynucleotidyl transferase activity in a cell line (molt-4) derived from the peripheral blood of a patient with acute lymphoblastic leukemia.

Authors:  B I Sahai Srivastava; J Minowada
Journal:  Biochem Biophys Res Commun       Date:  1973-04-02       Impact factor: 3.575

6.  A dye-buoyant-density method for the detection and isolation of closed circular duplex DNA: the closed circular DNA in HeLa cells.

Authors:  R Radloff; W Bauer; J Vinograd
Journal:  Proc Natl Acad Sci U S A       Date:  1967-05       Impact factor: 11.205

7.  Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA.

Authors:  S N Cohen; A C Chang; L Hsu
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

8.  Human papovavirus (JC): induction of brain tumors in hamsters.

Authors:  D L Walker; B L Padgett; G M ZuRhein; A E Albert; R F Marsh
Journal:  Science       Date:  1973-08-17       Impact factor: 47.728

9.  Human papovavirus, BK strain: biological studies including antigenic relationship to simian virus 40.

Authors:  K K Takemoto; M F Mullarkey
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

10.  Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas.

Authors:  G Klein; T Lindahl; M Jondal; W Leibold; J Menézes; K Nilsson; C Sundström
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

View more
  20 in total

1.  Expression of the small T antigen of Lymphotropic Papovavirus is sufficient to transform primary mouse embryo fibroblasts.

Authors:  Tushar Gupta; Maria Teresa Sáenz Robles; Rachel M Schowalter; Christopher B Buck; James M Pipas
Journal:  Virology       Date:  2015-10-27       Impact factor: 3.616

2.  Cell-type-specific control elements of the lymphotropic papovavirus enhancer.

Authors:  J R Erselius; B Jostes; A K Hatzopoulos; L Mosthaf; P Gruss
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

3.  PCR detection and DNA sequence analysis of the regulatory region of lymphotropic papovavirus in peripheral blood mononuclear cells of an immunocompromised rhesus macaque.

Authors:  John A Lednicky; Steven J Halvorson; Janet S Butel
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  Monkey B-lymphotropic papovavirus mutant capable of replicating in T-lymphoblastoid cells.

Authors:  T Kanda; K K Takemoto
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

5.  The cell surface receptor is a major determinant restricting the host range of the B-lymphotropic papovavirus.

Authors:  G Haun; O T Keppler; C T Bock; M Herrmann; H Zentgraf; M Pawlita
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

6.  Alignment of the genome of monkey B-lymphotropic papovavirus to the genomes of simian virus 40 and BK virus.

Authors:  T Kanda; K Yoshiike; K K Takemoto
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

7.  Monkey B-lymphotropic papovavirus DNA: nucleotide sequence of the region around the origin of replication.

Authors:  A Furuno; T Miyamura; K Yoshiike
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

8.  Lymphotropic papovavirus early region is specifically regulated transgenic mice and efficiently induces neoplasia.

Authors:  J D Chen; K Neilson; T Van Dyke
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

9.  Lymphotropic papovavirus transformation of hamster embryo cells.

Authors:  K K Takemoto; T Kanda
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

10.  Regulation of susceptibility and cell surface receptor for the B-lymphotropic papovavirus by N glycosylation.

Authors:  O T Keppler; M Herrmann; M Oppenländer; W Meschede; M Pawlita
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.